New York State Common Retirement Fund Sells 21,712 Shares of IQVIA Holdings Inc. (NYSE:IQV)

New York State Common Retirement Fund lowered its stake in shares of IQVIA Holdings Inc. (NYSE:IQV) by 16.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 107,928 shares of the medical research company’s stock after selling 21,712 shares during the period. New York State Common Retirement Fund’s holdings in IQVIA were worth $25,576,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. 1832 Asset Management L.P. increased its stake in shares of IQVIA by 472.3% in the second quarter. 1832 Asset Management L.P. now owns 456,335 shares of the medical research company’s stock worth $96,487,000 after purchasing an additional 376,595 shares in the last quarter. Renaissance Technologies LLC purchased a new stake in shares of IQVIA in the second quarter worth $70,610,000. Impax Asset Management Group plc boosted its position in shares of IQVIA by 19.3% during the 2nd quarter. Impax Asset Management Group plc now owns 1,635,201 shares of the medical research company’s stock valued at $344,998,000 after acquiring an additional 264,555 shares during the last quarter. Canada Pension Plan Investment Board grew its stake in IQVIA by 6.6% in the 2nd quarter. Canada Pension Plan Investment Board now owns 3,403,488 shares of the medical research company’s stock worth $719,634,000 after buying an additional 211,653 shares in the last quarter. Finally, D. E. Shaw & Co. Inc. increased its stake in IQVIA by 285.1% in the second quarter. D. E. Shaw & Co. Inc. now owns 268,552 shares of the medical research company’s stock valued at $56,783,000 after acquiring an additional 198,808 shares during the last quarter. 89.62% of the stock is owned by hedge funds and other institutional investors.

IQVIA Trading Up 1.6 %

Shares of NYSE:IQV opened at $209.16 on Monday. The stock’s 50-day simple moving average is $234.31 and its two-hundred day simple moving average is $229.76. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.85 and a current ratio of 0.81. The stock has a market capitalization of $38.13 billion, a price-to-earnings ratio of 27.45, a PEG ratio of 2.01 and a beta of 1.51. IQVIA Holdings Inc. has a 52-week low of $181.03 and a 52-week high of $261.73.

Analysts Set New Price Targets

A number of research analysts have commented on IQV shares. Truist Financial reduced their price target on shares of IQVIA from $300.00 to $286.00 and set a “buy” rating on the stock in a research report on Monday, October 14th. Deutsche Bank Aktiengesellschaft cut their price objective on IQVIA from $270.00 to $265.00 and set a “buy” rating on the stock in a research report on Friday. StockNews.com upgraded shares of IQVIA from a “hold” rating to a “buy” rating in a research report on Wednesday, October 30th. Morgan Stanley increased their price objective on IQVIA from $270.00 to $280.00 and gave the stock an “overweight” rating in a report on Tuesday, July 23rd. Finally, JPMorgan Chase & Co. dropped their price target on IQVIA from $288.00 to $279.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 23rd. Four analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $263.81.

Insiders Place Their Bets

In other IQVIA news, insider Eric Sherbet sold 1,300 shares of the company’s stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $246.33, for a total value of $320,229.00. Following the completion of the sale, the insider now owns 19,536 shares in the company, valued at $4,812,302.88. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders own 1.60% of the company’s stock.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.